SkinBioTherapeutics Plc (SBTX.L) LSE

14.25

+0.625(+4.59%)

Updated at December 24 12:20PM

Currency In GBp

Valuation

Market Cap16.77M
Enterprise Value16.78M
P/E Ratio-12.34
PEG Ratio-0.66
Price/Sales Ratio13.76
Price/Book Ratio7.08
Enterprise/Revenue13.69
Enterprise/EBITDA-16.1

Fiscal Year

Fiscal YearJune 30, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.96
Operating Margin-0.95

Management Effectiveness

Return On Assets-0.35
Return On Equity-0.69

Income Statement

Revenue4.64M
Revenue/Share0.01
Gross Profit2.71M
EBITDA-196,540
Net Income-696,253
Diluted EPS-0

Balance Sheet

Total Cash4.78M
Total Cash/Share0.01
Total Debt993,466
Total Debt/Equity0.23
Current Ratio1.79
Book Value Per Share0.02

Price History

52-Week Change-14.93
52-Week High27.5
52-Week Low12
Moving Average 50 Days15.27
Moving Average 200 Days17.35

Statistics

Average Volume1.15M
Shares Outstanding258.78M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A